Sulfasalazine
NDC 16571-261, Sulfasalazine, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-261
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219046
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-261 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SULFASALAZINE500 mg/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-261-01 | 16571026101 | 100 TABLET in 1 CONTAINER (16571-261-01) |
| 16571-261-30 | 16571026130 | 300 TABLET in 1 CONTAINER (16571-261-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3254432e-87a4-4af0-afd1-d9e6f1b0efd4
Use it
Look up 16571-261 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-261 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-261. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.